Presentation is loading. Please wait.

Presentation is loading. Please wait.

The guidelines for reversing warfarin and NOAC coagulopathies in patients with symptomatic ICH. ICH, intracerebral haemorrhage. The guidelines for reversing.

Published byColleen Nash Modified over 5 years ago

Similar presentations

Presentation on theme: "The guidelines for reversing warfarin and NOAC coagulopathies in patients with symptomatic ICH. ICH, intracerebral haemorrhage. The guidelines for reversing."— Presentation transcript:

1 The guidelines for reversing warfarin and NOAC coagulopathies in patients with symptomatic ICH. ICH, intracerebral haemorrhage. The guidelines for reversing warfarin and NOAC coagulopathies in patients with symptomatic ICH. ICH, intracerebral haemorrhage. Cyrus K Dastur, and Wengui Yu Stroke Vasc Neurol 2017;2:21-29 Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to

Download ppt "The guidelines for reversing warfarin and NOAC coagulopathies in patients with symptomatic ICH. ICH, intracerebral haemorrhage. The guidelines for reversing."

Similar presentations

Graph comparing baseline data with data collected following PDSA cycle 1 (initial introduction of the checklist). PDSA, plan do study act; IV, intravenous.

Graph comparing baseline data with data collected following PDSA cycle 1 (initial introduction of the checklist). PDSA, plan do study act; IV, intravenous.
Percentage of patients attending for GP steroid review following steroid letter. GP, general practitioner; LTOC, long-term oral corticosteroids. Percentage.

Percentage of patients attending for GP steroid review following steroid letter. GP, general practitioner; LTOC, long-term oral corticosteroids. Percentage.
Example of MRIs of a lacune from a haemorrhagic source (A,B), and from a lacunar infarct (C, D). Example of MRIs of a lacune from a haemorrhagic source.

Example of MRIs of a lacune from a haemorrhagic source (A,B), and from a lacunar infarct (C, D). Example of MRIs of a lacune from a haemorrhagic source.
STRIVE, STandards for Reporting and Imaging of Small Vessel Disease: example findings (upper), schematic representation (middle) and a summary of imaging.

STRIVE, STandards for Reporting and Imaging of Small Vessel Disease: example findings (upper), schematic representation (middle) and a summary of imaging.
Summary of project team improvement efforts

Summary of project team improvement efforts
Flow diversion concept: placement of a high-mesh density stent (flow diverter) in the parent vessel disrupts blood flow into the aneurysm (A and B), allowing.

Flow diversion concept: placement of a high-mesh density stent (flow diverter) in the parent vessel disrupts blood flow into the aneurysm (A and B), allowing.
WEB treatment of MCA bifurcation aneurysms.

WEB treatment of MCA bifurcation aneurysms.
Flow diversion treatment of a large left cavernous aneurysm with complete occlusion of the aneurysm demonstrated at 6-month follow-up angiogram. Flow diversion.

Flow diversion treatment of a large left cavernous aneurysm with complete occlusion of the aneurysm demonstrated at 6-month follow-up angiogram. Flow diversion.
Effect of interventions on % appointments not attended

Effect of interventions on % appointments not attended
Run chart for measure 2 (adjusted timely morning discharge which is the percentage of patients who left by noon out of those eligible for morning discharge.

Run chart for measure 2 (adjusted timely morning discharge which is the percentage of patients who left by noon out of those eligible for morning discharge.
The poster displayed across the wards and on our Trust intranet

The poster displayed across the wards and on our Trust intranet
Percentage of newborns admitted to neonatal intensive care unit with axillary temperature over 36.5°C on arrival (July 2016–April 2017). Percentage of.

Percentage of newborns admitted to neonatal intensive care unit with axillary temperature over 36.5°C on arrival (July 2016–April 2017). Percentage of.
Percentage of newborns admitted to neonatal intensive care unit with axillary temperature below 36°C on arrival (July 2016–April 2017). Percentage of newborns.

Percentage of newborns admitted to neonatal intensive care unit with axillary temperature below 36°C on arrival (July 2016–April 2017). Percentage of newborns.
Long-term appearances of lacunar infarcts (arrows: old stroke lesion on the follow-up scans). Long-term appearances of lacunar infarcts (arrows: old stroke.

Long-term appearances of lacunar infarcts (arrows: old stroke lesion on the follow-up scans). Long-term appearances of lacunar infarcts (arrows: old stroke.
This a Pareto chart showing the data obtained from auditing the steps in the discharge process. This a Pareto chart showing the data obtained from auditing.

This a Pareto chart showing the data obtained from auditing the steps in the discharge process. This a Pareto chart showing the data obtained from auditing.
Detection of microemboli by transcranial Doppler identifies high-risk asymptomatic carotid stenosis. Detection of microemboli by transcranial Doppler identifies.

Detection of microemboli by transcranial Doppler identifies high-risk asymptomatic carotid stenosis. Detection of microemboli by transcranial Doppler identifies.
Mortality from CHD and stroke in women and men, by country and year.

Mortality from CHD and stroke in women and men, by country and year.
Microemboli during deployment of a carotid stent.

Microemboli during deployment of a carotid stent.
STRIVE, STandards for Reporting and Imaging of Small Vessel Disease: example findings (upper), schematic representation (middle) and a summary of imaging.

STRIVE, STandards for Reporting and Imaging of Small Vessel Disease: example findings (upper), schematic representation (middle) and a summary of imaging.
Effects of statins (hydroxymethylglutarate (HMG) coenzyme A reductase inhibitors) on synthesis of ubiquinone (coenzyme Q10, CoQ10). Effects of statins.

Effects of statins (hydroxymethylglutarate (HMG) coenzyme A reductase inhibitors) on synthesis of ubiquinone (coenzyme Q10, CoQ10). Effects of statins.

Similar presentations

Ads by Google